首页> 外文期刊>Japanese Journal of Ophthalmology >Autoantibody against neuron-specific enolase found in glaucoma patients causes retinal dysfunction in vivo.
【24h】

Autoantibody against neuron-specific enolase found in glaucoma patients causes retinal dysfunction in vivo.

机译:在青光眼患者中发现的针对神经元特异性烯醇化酶的自身抗体会在体内引起视网膜功能障碍。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: In our recent paper, we have reported the presence of serum autoantibody against neuron-specific enolase (NSE) in patients with glaucoma. The purpose of the present study was to investigate further the pathological effects of anti-NSE antibody on retina by comparing them with the effects induced by N-methyl-D-aspartate (NMDA). METHODS: Either a glaucoma patient's serum or purified anti-NSE antibody, or 10-40 mM NMDA was intravitreously administered into Lewis rat eyes, and electrophysiological, histopathological, and biochemical evaluations were performed. In addition, the neuroprotective effects of anti-glaucoma drugs, such as timolol, betaxolol, nipradilol, and isopropyl unoprostone, and a calcium antagonist were also studied using these animal models. RESULTS: Electron microscopy revealed that intravitreal administration of a glaucoma patient's serum, which immunoreacted with retinal 50 kDa in Western blot analysis, and purified anti-NSE antibody induced retinal ganglion cell apoptosis in rat eyes. Functionally, these eyes showed a significant decrease in electroretinogram (ERG) responses and a remarkable decrease in rhodopsin phosphorylation reaction. These changes were comparable to the effects observed after the intravitreal administration of 20 mM NMDA. Co-administration of nipradilol, an alpha- and beta-blocker, with anti-NSE antibody or 20 mM NMDA caused marked recovery of the affected ERG responses within 2 weeks. In contrast, administration of timolol or betaxolol showed no recovery effect on the ERG responses. Among these drugs, only betaxolol showed a recovery effect on NMDA-induced decrease of rhodopsin phosphorylation. Nilvadipine functioned beneficially on both impaired ERG and rhodopsin phosphorylation reactions observed in rat eyes injected intravitreously with anti-NSE antibody or NMDA. These effects of nilvadipine were not changed by the addition of endothelin-1. In contrast, isopropyl unoprostone had no effect on these functions. CONCLUSION: These observations suggest that serum autoantibody against NSE found in some patients with glaucoma induces retinal dysfunction in vivo, similarly to NMDA.
机译:目的:在我们最近的论文中,我们报道了青光眼患者存在针对神经元特异性烯醇化酶(NSE)的血清自身抗体。本研究的目的是通过将NSE抗体与N-甲基-D-天冬氨酸(NMDA)诱导的效应进行比较,进一步研究抗NSE抗体对视网膜的病理效应。方法:对Lewis大鼠的眼睛玻璃体内给予青光眼患者的血清或纯化的抗NSE抗体或10-40 mM NMDA,并进行电生理,组织病理学和生化评估。此外,还使用这些动物模型研究了抗青光眼药物(例如噻吗洛尔,紫杉醇,尼帕地洛和异丙基unoprostone)的神经保护作用,以及钙拮抗剂。结果:电子显微镜检查显示,玻璃体腔内注射青光眼患者的血清,在Western blot分析中与视网膜50 kDa发生了免疫反应,并且纯化的抗NSE抗体诱导了大鼠眼中视网膜神经节细胞的凋亡。从功能上讲,这些眼睛的视网膜电图(ERG)反应明显降低,视紫红质的磷酸化反应也明显降低。这些变化与玻璃体内给予20 mM NMDA后观察到的效果相当。 nipradilol(一种α和β受体阻滞剂)与抗NSE抗体或20 mM NMDA并用可在2周内显着恢复受影响的ERG反应。相反,噻吗洛尔或紫杉醇的给药对ERG应答没有恢复作用。在这些药物中,只有紫杉醇对NMDA诱导的视紫红质磷酸化减少显示出恢复作用。尼伐地平对玻璃体腔注射抗NSE抗体或NMDA的大鼠眼睛中观察到的ERG和视紫红质磷酸化反应均有益。尼伐地平的这些作用不会因添加内皮素-1而改变。相反,异丙基unoprostone对这些功能没有影响。结论:这些观察结果表明,在某些青光眼患者中发现的针对NSE的血清自身抗体与NMDA类似,在体内可引起视网膜功能障碍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号